Key facts
- This page summarizes John P. Brancaccio's Form 4 filing for Hepion Pharmaceuticals, Inc. (HEPA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 21 Feb 2024, 20:01.
John P. Brancaccio - 19 Feb 2024 Form 4 Insider Report for Hepion Pharmaceuticals, Inc. (HEPA)
- Reporting relationship
- Chairman, Director
- Issuer ticker
- HEPA
- Reported as of
- 19 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Feb 2024, 20:01:32 UTC
- Prior SEC filing
- 28 Sep 2023
- Next SEC filing
- 01 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Brancaccio
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John P. Brancaccio filed Form 4 for Hepion Pharmaceuticals, Inc. (HEPA) on 21 Feb 2024.
Change
- Previous filing in this sequence was filed on 28 Sep 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HEPA
transaction
Derivative
Stock Options
Award
- Transaction value
- $0
- Shares
- +85,000
- Change %
- +584%
- Price
- $0.000000
- Shares after
- 99,563
- Date
- 19 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 85,000
- Exercise price
- $2.56
* marks a reported price that did not pass the local price check.